| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oocytes | 17 | 2026 | 282 | 3.820 |
Why?
|
| Ovarian Follicle | 17 | 2025 | 121 | 3.800 |
Why?
|
| Ovary | 20 | 2025 | 345 | 3.480 |
Why?
|
| Sumoylation | 5 | 2025 | 47 | 2.860 |
Why?
|
| Granulosa Cells | 16 | 2019 | 140 | 2.690 |
Why?
|
| Fertility | 11 | 2025 | 261 | 2.260 |
Why?
|
| Reproduction | 5 | 2025 | 210 | 1.970 |
Why?
|
| Oogenesis | 7 | 2025 | 50 | 1.900 |
Why?
|
| Germ Cells | 6 | 2023 | 201 | 1.460 |
Why?
|
| Granulosa Cell Tumor | 10 | 2019 | 38 | 1.410 |
Why?
|
| Inhibins | 6 | 2013 | 82 | 1.330 |
Why?
|
| Smad Proteins | 5 | 2016 | 43 | 1.240 |
Why?
|
| Transforming Growth Factor beta | 8 | 2017 | 450 | 1.230 |
Why?
|
| Mice, Knockout | 26 | 2026 | 3814 | 1.090 |
Why?
|
| Signal Transduction | 17 | 2021 | 4656 | 1.070 |
Why?
|
| Infertility, Female | 6 | 2025 | 146 | 1.020 |
Why?
|
| Mice | 40 | 2026 | 18172 | 1.020 |
Why?
|
| Animals | 55 | 2026 | 33698 | 1.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 3 | 2025 | 37 | 0.990 |
Why?
|
| NEDD8 Protein | 1 | 2026 | 20 | 0.970 |
Why?
|
| Primary Ovarian Insufficiency | 4 | 2021 | 50 | 0.920 |
Why?
|
| Giant Cells | 1 | 2025 | 33 | 0.900 |
Why?
|
| Homeodomain Proteins | 5 | 2023 | 558 | 0.890 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 7 | 2011 | 287 | 0.870 |
Why?
|
| Myostatin | 1 | 2025 | 22 | 0.870 |
Why?
|
| Transcription, Genetic | 3 | 2026 | 1364 | 0.850 |
Why?
|
| Ovarian Neoplasms | 6 | 2016 | 421 | 0.780 |
Why?
|
| Estrous Cycle | 3 | 2025 | 40 | 0.780 |
Why?
|
| Integrases | 2 | 2023 | 157 | 0.760 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2023 | 121 | 0.750 |
Why?
|
| Smad5 Protein | 3 | 2014 | 20 | 0.680 |
Why?
|
| Smad1 Protein | 3 | 2014 | 23 | 0.680 |
Why?
|
| Female | 54 | 2026 | 70285 | 0.680 |
Why?
|
| Smad4 Protein | 3 | 2012 | 57 | 0.670 |
Why?
|
| Growth Differentiation Factor 9 | 7 | 2013 | 50 | 0.670 |
Why?
|
| Mitochondria | 1 | 2026 | 768 | 0.650 |
Why?
|
| Transcription Factors | 8 | 2023 | 2404 | 0.610 |
Why?
|
| Cytokines | 4 | 2021 | 1342 | 0.600 |
Why?
|
| Meiosis | 4 | 2015 | 110 | 0.590 |
Why?
|
| Cell Communication | 1 | 2019 | 188 | 0.570 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 979 | 0.560 |
Why?
|
| Aging | 1 | 2025 | 1236 | 0.530 |
Why?
|
| Menopause | 1 | 2017 | 85 | 0.500 |
Why?
|
| Gene Expression Regulation | 8 | 2014 | 2323 | 0.500 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2012 | 127 | 0.500 |
Why?
|
| Reproductive Health | 1 | 2017 | 48 | 0.500 |
Why?
|
| Ovulation | 8 | 2012 | 102 | 0.490 |
Why?
|
| Oviducts | 1 | 2016 | 99 | 0.470 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2019 | 951 | 0.470 |
Why?
|
| Fallopian Tubes | 1 | 2016 | 66 | 0.460 |
Why?
|
| Longevity | 1 | 2017 | 175 | 0.460 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2015 | 25 | 0.460 |
Why?
|
| Uterus | 3 | 2016 | 545 | 0.460 |
Why?
|
| Spermatogenesis | 2 | 2015 | 166 | 0.440 |
Why?
|
| Activins | 4 | 2013 | 71 | 0.430 |
Why?
|
| Lipodystrophy | 2 | 2025 | 37 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 588 | 0.380 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 40 | 0.370 |
Why?
|
| Gonadotropins | 2 | 2015 | 31 | 0.350 |
Why?
|
| Egg Proteins | 2 | 2012 | 30 | 0.350 |
Why?
|
| Luteinization | 2 | 2010 | 12 | 0.320 |
Why?
|
| Adipose Tissue, White | 3 | 2025 | 97 | 0.290 |
Why?
|
| Embryo Implantation | 3 | 2016 | 219 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 4693 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2015 | 2010 | 0.290 |
Why?
|
| Humans | 33 | 2026 | 130154 | 0.270 |
Why?
|
| Inhibin-beta Subunits | 1 | 2007 | 18 | 0.260 |
Why?
|
| Testis | 2 | 2007 | 389 | 0.240 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2026 | 85 | 0.240 |
Why?
|
| Adipose Tissue, Beige | 1 | 2025 | 9 | 0.240 |
Why?
|
| Ubiquitination | 1 | 2026 | 174 | 0.230 |
Why?
|
| Oxidative Phosphorylation | 1 | 2026 | 141 | 0.230 |
Why?
|
| Gonads | 1 | 2004 | 32 | 0.220 |
Why?
|
| Transforming Growth Factors | 1 | 2004 | 18 | 0.220 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 714 | 0.220 |
Why?
|
| Mitochondrial Proteins | 1 | 2026 | 283 | 0.210 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 705 | 0.210 |
Why?
|
| Carcinogenesis | 3 | 2019 | 336 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 584 | 0.210 |
Why?
|
| Proteins | 3 | 2023 | 1005 | 0.210 |
Why?
|
| Cell Differentiation | 5 | 2015 | 1910 | 0.210 |
Why?
|
| Gene Deletion | 3 | 2021 | 766 | 0.200 |
Why?
|
| Zygote | 1 | 2023 | 28 | 0.200 |
Why?
|
| Bone Morphogenetic Protein 15 | 5 | 2007 | 44 | 0.200 |
Why?
|
| Reactive Oxygen Species | 1 | 2026 | 526 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 2329 | 0.190 |
Why?
|
| Male | 16 | 2025 | 64397 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1205 | 0.190 |
Why?
|
| Lysine | 1 | 2023 | 164 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 993 | 0.180 |
Why?
|
| Mammals | 1 | 2023 | 252 | 0.180 |
Why?
|
| Tissue Engineering | 1 | 2003 | 152 | 0.180 |
Why?
|
| Energy Metabolism | 2 | 2024 | 802 | 0.180 |
Why?
|
| Periodicity | 1 | 2021 | 48 | 0.170 |
Why?
|
| Bioreactors | 1 | 2002 | 43 | 0.170 |
Why?
|
| Models, Genetic | 1 | 2004 | 748 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4646 | 0.170 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 27 | 0.170 |
Why?
|
| Adipocytes, White | 1 | 2021 | 27 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 57 | 0.170 |
Why?
|
| Growth Substances | 1 | 2000 | 99 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 373 | 0.160 |
Why?
|
| Models, Biological | 4 | 2015 | 1376 | 0.150 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2019 | 3 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 613 | 0.150 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2010 | 176 | 0.150 |
Why?
|
| Smad2 Protein | 2 | 2009 | 54 | 0.150 |
Why?
|
| Smad3 Protein | 2 | 2009 | 53 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 1804 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2015 | 104 | 0.140 |
Why?
|
| Neoplasms | 1 | 2013 | 2980 | 0.130 |
Why?
|
| Genitalia | 1 | 2017 | 39 | 0.130 |
Why?
|
| Recombinant Proteins | 4 | 2007 | 1317 | 0.130 |
Why?
|
| Genetic Fitness | 1 | 2017 | 34 | 0.130 |
Why?
|
| Age Factors | 2 | 2017 | 2823 | 0.130 |
Why?
|
| Health Status Indicators | 1 | 2017 | 111 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2010 | 647 | 0.120 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 114 | 0.120 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1592 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 400 | 0.120 |
Why?
|
| Models, Animal | 1 | 2017 | 450 | 0.110 |
Why?
|
| Placentation | 1 | 2015 | 59 | 0.110 |
Why?
|
| Health Status | 1 | 2017 | 371 | 0.110 |
Why?
|
| Forkhead Box Protein O3 | 2 | 2015 | 31 | 0.110 |
Why?
|
| Cumulus Cells | 3 | 2010 | 42 | 0.100 |
Why?
|
| Pregnancy | 5 | 2016 | 7396 | 0.100 |
Why?
|
| Tissue Distribution | 2 | 2006 | 362 | 0.100 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 436 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 142 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 248 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 33 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 86 | 0.100 |
Why?
|
| Gene Expression | 3 | 2007 | 1481 | 0.100 |
Why?
|
| Ligands | 2 | 2004 | 481 | 0.100 |
Why?
|
| Base Sequence | 3 | 2006 | 2729 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 785 | 0.090 |
Why?
|
| Zona Pellucida Glycoproteins | 1 | 2012 | 8 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 223 | 0.090 |
Why?
|
| Organ Size | 1 | 2013 | 408 | 0.090 |
Why?
|
| Animals, Newborn | 3 | 2011 | 1018 | 0.090 |
Why?
|
| Enterococcus | 1 | 2012 | 30 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 407 | 0.090 |
Why?
|
| Metagenome | 1 | 2012 | 139 | 0.080 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 12 | 0.080 |
Why?
|
| TATA-Binding Protein Associated Factors | 2 | 2007 | 8 | 0.080 |
Why?
|
| Transcription Factor TFIID | 2 | 2007 | 15 | 0.080 |
Why?
|
| Transfection | 1 | 2012 | 961 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2012 | 1013 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 662 | 0.080 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2010 | 10 | 0.080 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2010 | 32 | 0.080 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 265 | 0.080 |
Why?
|
| Colitis | 1 | 2012 | 166 | 0.080 |
Why?
|
| Hedgehog Proteins | 2 | 2010 | 198 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1826 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 420 | 0.080 |
Why?
|
| Aromatase | 1 | 2009 | 23 | 0.080 |
Why?
|
| Receptors, FSH | 1 | 2009 | 18 | 0.080 |
Why?
|
| Sexual Maturation | 1 | 2009 | 45 | 0.080 |
Why?
|
| Apoptosis | 2 | 2014 | 1830 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2019 | 824 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 263 | 0.070 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2009 | 40 | 0.070 |
Why?
|
| Genomics | 1 | 2017 | 1618 | 0.070 |
Why?
|
| Multigene Family | 1 | 2010 | 289 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2463 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 1209 | 0.070 |
Why?
|
| Cell Line | 2 | 2004 | 2554 | 0.070 |
Why?
|
| Smad8 Protein | 1 | 2007 | 5 | 0.070 |
Why?
|
| Sertoli Cell Tumor | 1 | 2007 | 7 | 0.070 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2007 | 9 | 0.070 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2007 | 6 | 0.070 |
Why?
|
| Corpus Luteum | 1 | 2007 | 24 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 323 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 281 | 0.060 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 112 | 0.060 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2006 | 28 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2007 | 191 | 0.060 |
Why?
|
| Embryo, Mammalian | 2 | 2006 | 404 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2009 | 1481 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 3463 | 0.060 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2005 | 11 | 0.060 |
Why?
|
| Thermogenesis | 1 | 2025 | 56 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2007 | 2553 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2007 | 2887 | 0.060 |
Why?
|
| DNA Primers | 1 | 2006 | 600 | 0.060 |
Why?
|
| Steroids | 1 | 2006 | 169 | 0.060 |
Why?
|
| Spermatocytes | 1 | 2004 | 22 | 0.060 |
Why?
|
| Cholesterol | 1 | 2007 | 537 | 0.050 |
Why?
|
| Genes, Homeobox | 1 | 2004 | 61 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 2390 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2004 | 65 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 234 | 0.050 |
Why?
|
| Hexuronic Acids | 1 | 2003 | 6 | 0.050 |
Why?
|
| Glucuronic Acid | 1 | 2003 | 13 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2025 | 268 | 0.050 |
Why?
|
| Alginates | 1 | 2003 | 23 | 0.050 |
Why?
|
| Heterozygote | 1 | 2006 | 722 | 0.050 |
Why?
|
| Microspheres | 1 | 2003 | 66 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2005 | 200 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 583 | 0.050 |
Why?
|
| Phenotype | 1 | 2013 | 4464 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 305 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2004 | 152 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 716 | 0.050 |
Why?
|
| Hydrogels | 1 | 2003 | 92 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2004 | 322 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10953 | 0.050 |
Why?
|
| Follicular Atresia | 1 | 2002 | 2 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2002 | 29 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 273 | 0.050 |
Why?
|
| Exons | 1 | 2004 | 759 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1045 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2007 | 997 | 0.050 |
Why?
|
| Chromatography | 1 | 2002 | 29 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2002 | 67 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 83 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2002 | 151 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2002 | 165 | 0.040 |
Why?
|
| Biological Assay | 1 | 2002 | 105 | 0.040 |
Why?
|
| Reference Standards | 1 | 2002 | 231 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 674 | 0.040 |
Why?
|
| RNA | 1 | 2004 | 511 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 89 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1606 | 0.040 |
Why?
|
| Adipokines | 1 | 2021 | 118 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2000 | 54 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 2000 | 73 | 0.040 |
Why?
|
| Cyclin D3 | 1 | 2019 | 11 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2019 | 57 | 0.040 |
Why?
|
| Infant | 2 | 2016 | 13276 | 0.040 |
Why?
|
| Body Composition | 1 | 2021 | 541 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2016 | 15009 | 0.030 |
Why?
|
| Mutation | 2 | 2007 | 6070 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1996 | 31 | 0.030 |
Why?
|
| Child | 3 | 2016 | 26181 | 0.030 |
Why?
|
| Puberty, Precocious | 1 | 2016 | 25 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2016 | 152 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2021 | 685 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1996 | 139 | 0.030 |
Why?
|
| Adolescent | 2 | 2016 | 20802 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 237 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 875 | 0.030 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2015 | 10 | 0.030 |
Why?
|
| Keratin-8 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 46 | 0.030 |
Why?
|
| Lectins | 1 | 2015 | 50 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 387 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 99 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 411 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 83 | 0.030 |
Why?
|
| Genistein | 1 | 2014 | 40 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 62 | 0.030 |
Why?
|
| Decidua | 1 | 2015 | 144 | 0.030 |
Why?
|
| Trophoblasts | 1 | 2015 | 114 | 0.030 |
Why?
|
| Animal Feed | 1 | 2014 | 80 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2007 | 1933 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1996 | 257 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 6178 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 37 | 0.030 |
Why?
|
| Adult | 4 | 2015 | 31042 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 351 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1278 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 832 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2012 | 48 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 316 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 426 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 472 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 378 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 679 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1267 | 0.020 |
Why?
|
| Hormones | 1 | 2010 | 162 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 1097 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2007 | 59 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 4848 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2007 | 212 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3714 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 354 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 891 | 0.020 |
Why?
|
| Glycolysis | 1 | 2007 | 174 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 422 | 0.010 |
Why?
|
| X Chromosome | 1 | 2007 | 326 | 0.010 |
Why?
|
| Pyrroles | 1 | 2007 | 189 | 0.010 |
Why?
|
| Interferon Inducers | 1 | 2005 | 6 | 0.010 |
Why?
|
| Poly I-C | 1 | 2005 | 20 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 622 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2005 | 56 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 269 | 0.010 |
Why?
|
| Hyaluronan Synthases | 1 | 2004 | 13 | 0.010 |
Why?
|
| Serum Amyloid P-Component | 1 | 2004 | 14 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 64 | 0.010 |
Why?
|
| Pregnancy Rate | 1 | 2004 | 39 | 0.010 |
Why?
|
| Interferons | 1 | 2005 | 134 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 248 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 117 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 318 | 0.010 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 63 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 122 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 354 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2004 | 169 | 0.010 |
Why?
|
| ROC Curve | 1 | 2004 | 609 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 614 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 571 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 448 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12843 | 0.010 |
Why?
|
| Activin Receptors | 1 | 2000 | 14 | 0.010 |
Why?
|
| Membranes | 1 | 2000 | 14 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 1207 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2000 | 78 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 421 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 500 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 778 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 806 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 2289 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 17554 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1588 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1996 | 31 | 0.010 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1996 | 34 | 0.010 |
Why?
|
| Heat Shock Transcription Factors | 1 | 1996 | 21 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1996 | 52 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 395 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1996 | 345 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 28331 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1996 | 689 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 975 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 732 | 0.010 |
Why?
|
| Monocytes | 1 | 1996 | 335 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 1076 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 151 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 360 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 3378 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1996 | 1571 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 1400 | 0.010 |
Why?
|
| Inflammation | 1 | 1996 | 1481 | 0.000 |
Why?
|